Sign in

CIK 0001636651

  • Non-accelerated filer
  • Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465270895
Phone
+1 212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-07 Friedman Bart Director Grant or award +8,789 $2.56 $22K 8,789
2026-02-26 Friedman Bart Director Grant or award · Employee Stock Option (Right to Buy) +65,000 65,000
2025-02-20 Friedman Bart Director Grant or award · Stock Option (right to buy) +45,000 45,000
2024-12-12 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2024-02-22 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-02-23 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-04-08 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +69,424 69,424
2022-02-03 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2021-06-11 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2021-05-17 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +1,750 1,750
2020-06-05 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +13,250 13,250
2019-11-13 Friedman Bart Director Grant or award · Stock Option (right to buy) +7,437 7,437
2019-06-10 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +5,813 5,813
2018-06-07 Friedman Bart Director Grant or award · Stock Option (Right to Buy) +5,813 5,813

Page 1 of 1 · 14 trades